DEVELOPMENT OF AN IMMUNOTHERAPEUTIC DELIVERY PLATFORM USING ADIPOSE-DERIVED MESENCHYMAL STEM CELLS

$239,903FY2017Department of the ArmyDOD

Autoimmune Technologies, Llc, New Orleans LA

Investigators